RxDoctor Payments Data

Aya Pauley

Physician Assistant · Orange City, FLNPI 1477502888

Payments from drug & device makers

$2,727in general payments, 2019–2025

Across 116 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$502
  • AstraZeneca$496
  • Calliditas Therapeutics US Inc.$321
  • Otsuka America Pharmaceutical, Inc.$262
  • Baxter Healthcare$154
  • OPKO Pharmaceuticals, LLC$122
  • plus $869 from 17 others

What the payments were for

  • Food & beverage$2,42889%
  • Education$29911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,727 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$114,171
FarxigaDapagliflozin Propanediol96$89,487
KerendiaFinerenone11$13,218
LokelmaSodium Zirconium Cyclosilicate11$7,360
Cinacalcet Hcl33$4,713
Calcitriol162$2,692
Hydralazine Hcl77$1,432
Bumetanide36$1,346
Nifedipine ErNifedipine33$1,340
Amlodipine Besylate140$1,157
Doxazosin Mesylate36$839
Losartan Potassium88$837
Sevelamer Carbonate12$663
Spironolactone39$607
Potassium Chloride12$574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$29$114,17195 claims
AstraZenecaFarxiga, Lokelma$496$96,848107 claims
BayerKerendia$100$13,21811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Orange City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →